1. |
邬昊, 吕青. 全球及中国乳腺癌的流行病学趋势及防控启示: 2018–2022年《全球癌症统计报告》解读. 中国普外基础与临床杂志, 2024, 31(7): 796-802.
|
2. |
Lin M, Wu S. Ultrasound classification of non-mass breast lesions following BI-RADS presents high positive predictive value. PLoS One, 2022, 17(11): e0278299.
|
3. |
Zheng X, Li F, Xuan ZD, et al. Combination of shear wave elastography and BI-RADS in identification of solid breast masses. BMC Med Imaging, 2021, 21(1): 183.
|
4. |
Yi J, Ren L, Li D, et al. Trefoil factor 1 (TFF1) is a potential prognostic biomarker with functional significance in breast cancers. Biomed Pharmacother, 2020, 124: 109827.
|
5. |
Xue F, Meng Y, Jiang J. Diagnostic value of dynamic enhanced magnetic resonance imaging combined with serum CA15-3, CYFRA21-1, and TFF1 for Breast Cancer. J Healthc Eng, 2022, 2022: 7984591.
|
6. |
李兵, 冀建峰, 吴志华, 等. 彩色多普勒超声联合血清CEA、CA125、TK1、TFF1对乳腺癌的诊断价值研究. 现代生物医学进展, 2023, 23(16): 3072-3076.
|
7. |
Moghaddam ST, Forghanifard MM. Clinicopathological relevance of stem cell marker growth and differentiation factor 3 in esophageal squamous cell carcinoma. Explor Target Antitumor Ther, 2023, 4(2): 217-226.
|
8. |
王智宝, 孙宏, 崔伟, 等. 多模态磁共振成像联合血清GDF3、HSP90A诊断乳腺癌的临床价值. 中国CT和MRI杂志, 2023, 21(8): 85-87.
|
9. |
Zhang YN, Xia KR, Li CY, et al. Review of breast cancer pathologigcal image processing. Biomed Res Int, 2021, 2021: 1994764.
|
10. |
Kashyap D, Pal D, Sharma R, et al. Global increase in breast cancer incidence: risk factors and preventive measures. Biomed Res Int, 2022, 2022: 9605439.
|
11. |
Liu J, Zhao H, Huang Y, et al. Genome-wide cell-free DNA methylation analyses improve accuracy of non-invasive diagnostic imaging for early-stage breast cancer. Mol Cancer, 2021, 20(1): 36.
|
12. |
粟世桃, 黄健源, 黄炫彰, 等. 乳腺结节超声BI-RADS分类3~5类的量化评分研究. 中国超声医学杂志, 2021, 37(1): 27-30.
|
13. |
孙杨, 林子梅, 骆洁丽, 等. 超声BI-RADS分类对特殊类型乳腺癌的诊断价值. 中华超声影像学杂志, 2022, 31(1): 37-42.
|
14. |
张耀辉, 郑章增, 高星. 超声BI-RADS分类联合SWE技术鉴别诊断乳腺肿块良恶性的价值研究. 实用癌症杂志, 2022, 37(10): 1689-1691,1700.
|
15. |
杨娟. BI-RADS超声分类联合超声剪切波弹性成像对乳腺癌的诊断价值. 微创医学, 2022, 17(3): 342-344,379.
|
16. |
杨锦俊. 超声BI-RADS分类在乳腺癌诊断中的应用价值. 影像研究与医学应用, 2023, 7(1): 179-181.
|
17. |
杨小欢, 王海琴, 贾储瑜, 等. 超声弹性成像5分法联合BI-RADS分级对乳腺病变的诊断价值. 中国药物与临床, 2019, 19(5): 728-730.
|
18. |
Pegg HJ, Harrison H, Rogerson C, et al. The RUNX transcriptional coregulator, CBFβ, suppresses migration of ER+ breast cancer cells by repressing ERα-mediated expression of the migratory factor TFF1. Mol Cancer Res, 2019, 17(5): 1015-1023.
|
19. |
Cui R, Wang C, Zhao Q, et al. Serum carboxypeptidase n1 serves as a potential biomarker complementing CA15-3 for breast cancer. Anticancer Agents Med Chem, 2020, 20(17): 2053-2065.
|
20. |
马云瑶, 薛超, 刘海涛, 等. 弥散加权成像联合血清CEA、TFF1、sE-cadherin对乳腺良恶性肿块的鉴别价值研究. 现代生物医学进展, 2023, 23(17): 3273-3277.
|
21. |
毛平, 成莉, 黄秀兰, 等. CA153、TSGF、HE4和GDF3联合检测在乳腺癌诊断中的意义. 国际检验医学杂志, 2019, 40(6): 758-761.
|
22. |
王绪麟, 孟娟, 李慧璇, 等. 彩色多普勒超声结合血清CA153、MUC1、GDF3对早期乳腺癌的诊断价值研究. 现代生物医学进展, 2023, 23(16): 3169-3172,3128.
|